Related stocks: Biological Products, (No Diagnostic Substances)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF not applicable to ATYR
aTYR PHARMA INChas no history of positive free cash flow, so a DCF model can't project a meaningful intrinsic value.